Literature DB >> 8513284

Platelet-activating factor and its methoxy-analogue ET-18-OCH3 stimulate immediate early gene expression in rat astroglial cultures.

P Dell' Albani1, D F Condorelli, G Mudò, C Amico, M Bindoni, N Belluardo.   

Abstract

In the present paper we analyzed c-fos and zif/268 expression in rat primary astroglial cell cultures after treatment with Platelet-activating Factor (PAF) and its 2-O-methyl-analogue, 1-O-octadecyl-2-O-methoxy-glycero-3-phosphocholine (ET-18-OCH3). Both compounds, at a dose (2 microM) that did not produce toxic effects on astroglial cells, induced a rapid and transient increase of c-fos and zif/268 mRNA level. Pretreatment of astroglial cells with the PAF antagonist BN50730 (5 microM) 10 min prior to the addition of alkyl-phospholipids almost completely prevented the activation of the immediate early genes. On the contrary triazolam, another PAF inhibitor, did not block PAF induced gene expression when added to the medium at 5 microM concentration. ET-18-OCH3 effect on gene expression is blocked by the same antagonist (BN50730) which is effective in inhibiting PAF effect on astrocytes, suggesting that both substances act through the same binding site. Results obtained support the view that astroglial cells are a cellular target for this lipid mediator, and, like macrophages, respond to its methoxy-analogue.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8513284     DOI: 10.1016/0197-0186(93)90031-y

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  2 in total

1.  The ether lipid 1-octadecyl-2-methyl-rac-glycero-3-phosphocholine induces expression of fos and jun proto-oncogenes and activates AP-1 transcription factor in human leukaemic cells.

Authors:  F Mollinedo; C Gajate; M Modolell
Journal:  Biochem J       Date:  1994-09-01       Impact factor: 3.857

2.  Role of astrocytes in pathogenesis of ischemic brain injury.

Authors:  B Gabryel; H I Trzeciak
Journal:  Neurotox Res       Date:  2001-04       Impact factor: 3.911

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.